This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
7 Top Mid-Cap Stocks Set to Beat Earnings Estimates Next Week
by Nalak Das
Seven mid-cap stocks ??? Camping World (CWH), LCI Industries (LCII), DCP Midstream (DCP), Nu Skin (NUS), Advanced Energy (AEIS), Advanced Drainage (WMS) and PennyMac (PFSI) ??? are poised to beat earnings estimates next week.
Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Raises 2020 View Despite Soft Q3 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales decline year over year across all geographies in third-quarter 2020. Nevertheless, better-than-expected rebound leads management to raise 2020 view.
Here's How Colgate (CL) Looks Ahead of Q3 Earnings Report
by Zacks Equity Research
Colgate's (CL) Q3 performance is expected to have benefited from strong demand for essential goods, robust e-commerce sales and a booming pet business despite higher costs and currency.
Keurig (KDP) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Keurig (KDP) is expected to have benefited from strong demand for packaged beverages and coffee due to increased at-home consumption trends. Declines at the away-from-home channel have been ailing.
Things You Need to Know Before Newell's (NWL) Q3 Earnings
by Zacks Equity Research
Despite uncertain COVID-19 impacts, Newell's (NWL) Q3 results are likely to have gained from robust consumption patterns, strong e-commerce sales and the Project FUEL plan.
Altria (MO) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results are likely to reflect gains from pricing and strength in oral tobacco products. However, cigarette volumes have been soft for a while.
Here's All You Should Note Before Kellogg's (K) Q3 Earnings
by Zacks Equity Research
Kellogg's (K) third-quarter results are likely to reflect strength in the retail business due to increased pandemic-led demand. However, soft away-from-home food demand and high costs are concerns.
Molson Coors (TAP) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Molson Coors (TAP) has been benefiting from diligent cost-saving efforts, innovation and premiumization. However, closures of on-premise channels and supply-chain constraints have been concerning.
All You Should Know Before Church & Dwight (CHD) Q3 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2020 results are likely to reflect increased demand for household cleaning products amid the pandemic, though escalated costs are a concern.
Factors Likely to Decide Archer Daniels' (ADM) Q3 Earnings
by Zacks Equity Research
Soft results across the Carbohydrate Solutions segment and higher SG&A costs might show on Archer Daniels' (ADM) third-quarter 2020. However, its Nutrition unit bodes well.
Boston Beer (SAM) Rises on Q3 Earnings Beat, Updated View
by Zacks Equity Research
Boston Beer (SAM) witnesses continued strength in depletions and shipments in Q3, owing to momentum in Truly Hard Seltzer and Twisted Tea brands. This aids top and bottom-line growth in Q3.
What's in Store for Service Corporation's (SCI) Q3 Earnings?
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2020 results are likely to reflect revenue gains from increased funerals due to the pandemic-led deaths, though preneed sales have been soft.
Here's What You Should Know Ahead of FEMSA's (FMX) Q3 Earnings
by Zacks Equity Research
FEMSA (FMX) has been witnessing softness across all segments, owing to the coronavirus-led restrictions, which are likely to have resulted in reduced traffic trends in the third quarter.
All You Should Know Before Beyond Meat's (BYND) Q3 Earnings
by Zacks Equity Research
Beyond Meat's (BYND) third-quarter 2020 results are likely to reflect solid retail volumes owing to higher at-home consumption. However, foodservice sales are likely to be soft due to the pandemic.
What's in the Offing for AB InBev (BUD) in Q3 Earnings?
by Zacks Equity Research
AB InBev's (BUD) Q3 results are expected to reflect continued impacts of softer-than-normal volumes as well as higher costs. The reopening of on-premise and e-commerce growth remain positives.
Things to Know Ahead of Boston Beer's (SAM) Q3 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q3 results are likely to reflect continued gains from strength in depletions and shipments. Disruptions in on-premise and higher costs are expected to have marred its performance.
Procter & Gamble (PG) Q1 Earnings & Sales Beat, Stock Up
by Zacks Equity Research
Procter & Gamble's (PG) first-quarter fiscal 2021 results reflect top-line gains across all segments as well as a rise in organic shipment volume, and improved pricing and mix.
Will Coca-Cola (KO) Retain Positive Earnings Trend in Q3?
by Zacks Equity Research
Coca-Cola's (KO) third-quarter 2020 results are expected to reflect benefits from growth of e-commerce and gradually improving away-from-home trends as restrictions ease.
Here's Why Nu Skin (NUS) is Up About 20% in Three Months
by Zacks Equity Research
Nu Skin's (NUS) focus on empowering sales leaders through engaging technology platforms is yielding.
All You Should Know Before Philip Morris' (PM) Q3 Earnings
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2020 results are likely to reflect soft duty-free sales due to the pandemic-led travel restrictions. However, strength in reduced-risk products should aid.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Should Value Investors Buy Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Nu Skin Enterprises (NUS) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Why Nu Skin (NUS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.